Prospect of dengue vaccine development with halal process-based technology
Dengue disease is still a global health problem, according to WHO, which reported cases increased more than eight times over the last two decades. The vector control has been developed, but the dengue fever outbreak cannot be prevented. Meanwhile, there is no dengue antiviral drug until now. Dengue...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Tagungsbericht |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | |
| container_title | |
| container_volume | 2606 |
| creator | Lestari, Christina Safira Whinie Handayani, Sarwo Novientri, Gissi |
| description | Dengue disease is still a global health problem, according to WHO, which reported cases increased more than eight times over the last two decades. The vector control has been developed, but the dengue fever outbreak cannot be prevented. Meanwhile, there is no dengue antiviral drug until now. Dengue vaccine is one of the potentials to prevent dengue fever outbreaks. For Muslim-majority countries, it is essential to use a halal dengue vaccine technology platform. This study aims to explore technology platforms that have prospects for producing halal products. Among several technology platforms that have been developed for the dengue vaccine, the recombinant subunit vaccine and DNA vaccine have the prospect of producing halal vaccine products. In addition, safety aspects and affordable prices also need attention. |
| doi_str_mv | 10.1063/5.0118656 |
| format | Conference Proceeding |
| fullrecord | <record><control><sourceid>proquest_scita</sourceid><recordid>TN_cdi_proquest_journals_2760676143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2760676143</sourcerecordid><originalsourceid>FETCH-LOGICAL-p98f-d2659c87e6ad130f487af6e4c88d2a0c9ed6f7117e840c9e14ffe63d5af03c5f3</originalsourceid><addsrcrecordid>eNp9kE9LAzEUxIMoWKsHv0HAm7A12fzdoxStSkEPPXgLMXlpt2w36yat9Nu7pQVvnh4DP2bmDUK3lEwokexBTAilWgp5hkZUCFooSeU5GhFS8aLk7PMSXaW0JqSslNIj9PbRx9SByzgG7KFdbgHvrHN1C4PcQRO7DbQZ_9R5hVe2sQ3u-uggpeLLJvA4g1u1sYnL_TW6CLZJcHO6Y7R4flpMX4r5--x1-jgvukqHwpdSVE4rkNZTRgLXygYJ3GntS0tcBV4GRakCzQ-K8hBAMi9sIMyJwMbo7mg79PjeQspmHbd9OySaUkkih4c5G6j7I5VcnW2uY2u6vt7Yfm8oMYepjDCnqf6Dd7H_A03nA_sFqu9qyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>conference_proceeding</recordtype><pqid>2760676143</pqid></control><display><type>conference_proceeding</type><title>Prospect of dengue vaccine development with halal process-based technology</title><source>AIP Journals Complete</source><creator>Lestari, Christina Safira Whinie ; Handayani, Sarwo ; Novientri, Gissi</creator><contributor>Khaerunnisa, Isyana ; Harmoko, Rikno ; Nuryana, Isa ; Bayu, Asep ; Sarwono, Ki Ageng ; Izzati, Fauzia Nurul ; Rahmawati, Siti Irma</contributor><creatorcontrib>Lestari, Christina Safira Whinie ; Handayani, Sarwo ; Novientri, Gissi ; Khaerunnisa, Isyana ; Harmoko, Rikno ; Nuryana, Isa ; Bayu, Asep ; Sarwono, Ki Ageng ; Izzati, Fauzia Nurul ; Rahmawati, Siti Irma</creatorcontrib><description>Dengue disease is still a global health problem, according to WHO, which reported cases increased more than eight times over the last two decades. The vector control has been developed, but the dengue fever outbreak cannot be prevented. Meanwhile, there is no dengue antiviral drug until now. Dengue vaccine is one of the potentials to prevent dengue fever outbreaks. For Muslim-majority countries, it is essential to use a halal dengue vaccine technology platform. This study aims to explore technology platforms that have prospects for producing halal products. Among several technology platforms that have been developed for the dengue vaccine, the recombinant subunit vaccine and DNA vaccine have the prospect of producing halal vaccine products. In addition, safety aspects and affordable prices also need attention.</description><identifier>ISSN: 0094-243X</identifier><identifier>EISSN: 1551-7616</identifier><identifier>DOI: 10.1063/5.0118656</identifier><identifier>CODEN: APCPCS</identifier><language>eng</language><publisher>Melville: American Institute of Physics</publisher><subject>Outbreaks ; Platforms ; Product safety ; Public health ; Vaccines ; Viral diseases</subject><ispartof>AIP conference proceedings, 2023, Vol.2606 (1)</ispartof><rights>Author(s)</rights><rights>2023 Author(s). Published by AIP Publishing.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://pubs.aip.org/acp/article-lookup/doi/10.1063/5.0118656$$EHTML$$P50$$Gscitation$$H</linktohtml><link.rule.ids>309,310,314,777,781,786,787,791,4499,23912,23913,25122,27906,27907,76134</link.rule.ids></links><search><contributor>Khaerunnisa, Isyana</contributor><contributor>Harmoko, Rikno</contributor><contributor>Nuryana, Isa</contributor><contributor>Bayu, Asep</contributor><contributor>Sarwono, Ki Ageng</contributor><contributor>Izzati, Fauzia Nurul</contributor><contributor>Rahmawati, Siti Irma</contributor><creatorcontrib>Lestari, Christina Safira Whinie</creatorcontrib><creatorcontrib>Handayani, Sarwo</creatorcontrib><creatorcontrib>Novientri, Gissi</creatorcontrib><title>Prospect of dengue vaccine development with halal process-based technology</title><title>AIP conference proceedings</title><description>Dengue disease is still a global health problem, according to WHO, which reported cases increased more than eight times over the last two decades. The vector control has been developed, but the dengue fever outbreak cannot be prevented. Meanwhile, there is no dengue antiviral drug until now. Dengue vaccine is one of the potentials to prevent dengue fever outbreaks. For Muslim-majority countries, it is essential to use a halal dengue vaccine technology platform. This study aims to explore technology platforms that have prospects for producing halal products. Among several technology platforms that have been developed for the dengue vaccine, the recombinant subunit vaccine and DNA vaccine have the prospect of producing halal vaccine products. In addition, safety aspects and affordable prices also need attention.</description><subject>Outbreaks</subject><subject>Platforms</subject><subject>Product safety</subject><subject>Public health</subject><subject>Vaccines</subject><subject>Viral diseases</subject><issn>0094-243X</issn><issn>1551-7616</issn><fulltext>true</fulltext><rsrctype>conference_proceeding</rsrctype><creationdate>2023</creationdate><recordtype>conference_proceeding</recordtype><recordid>eNp9kE9LAzEUxIMoWKsHv0HAm7A12fzdoxStSkEPPXgLMXlpt2w36yat9Nu7pQVvnh4DP2bmDUK3lEwokexBTAilWgp5hkZUCFooSeU5GhFS8aLk7PMSXaW0JqSslNIj9PbRx9SByzgG7KFdbgHvrHN1C4PcQRO7DbQZ_9R5hVe2sQ3u-uggpeLLJvA4g1u1sYnL_TW6CLZJcHO6Y7R4flpMX4r5--x1-jgvukqHwpdSVE4rkNZTRgLXygYJ3GntS0tcBV4GRakCzQ-K8hBAMi9sIMyJwMbo7mg79PjeQspmHbd9OySaUkkih4c5G6j7I5VcnW2uY2u6vt7Yfm8oMYepjDCnqf6Dd7H_A03nA_sFqu9qyw</recordid><startdate>20230104</startdate><enddate>20230104</enddate><creator>Lestari, Christina Safira Whinie</creator><creator>Handayani, Sarwo</creator><creator>Novientri, Gissi</creator><general>American Institute of Physics</general><scope>8FD</scope><scope>H8D</scope><scope>L7M</scope></search><sort><creationdate>20230104</creationdate><title>Prospect of dengue vaccine development with halal process-based technology</title><author>Lestari, Christina Safira Whinie ; Handayani, Sarwo ; Novientri, Gissi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p98f-d2659c87e6ad130f487af6e4c88d2a0c9ed6f7117e840c9e14ffe63d5af03c5f3</frbrgroupid><rsrctype>conference_proceedings</rsrctype><prefilter>conference_proceedings</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Outbreaks</topic><topic>Platforms</topic><topic>Product safety</topic><topic>Public health</topic><topic>Vaccines</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lestari, Christina Safira Whinie</creatorcontrib><creatorcontrib>Handayani, Sarwo</creatorcontrib><creatorcontrib>Novientri, Gissi</creatorcontrib><collection>Technology Research Database</collection><collection>Aerospace Database</collection><collection>Advanced Technologies Database with Aerospace</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lestari, Christina Safira Whinie</au><au>Handayani, Sarwo</au><au>Novientri, Gissi</au><au>Khaerunnisa, Isyana</au><au>Harmoko, Rikno</au><au>Nuryana, Isa</au><au>Bayu, Asep</au><au>Sarwono, Ki Ageng</au><au>Izzati, Fauzia Nurul</au><au>Rahmawati, Siti Irma</au><format>book</format><genre>proceeding</genre><ristype>CONF</ristype><atitle>Prospect of dengue vaccine development with halal process-based technology</atitle><btitle>AIP conference proceedings</btitle><date>2023-01-04</date><risdate>2023</risdate><volume>2606</volume><issue>1</issue><issn>0094-243X</issn><eissn>1551-7616</eissn><coden>APCPCS</coden><abstract>Dengue disease is still a global health problem, according to WHO, which reported cases increased more than eight times over the last two decades. The vector control has been developed, but the dengue fever outbreak cannot be prevented. Meanwhile, there is no dengue antiviral drug until now. Dengue vaccine is one of the potentials to prevent dengue fever outbreaks. For Muslim-majority countries, it is essential to use a halal dengue vaccine technology platform. This study aims to explore technology platforms that have prospects for producing halal products. Among several technology platforms that have been developed for the dengue vaccine, the recombinant subunit vaccine and DNA vaccine have the prospect of producing halal vaccine products. In addition, safety aspects and affordable prices also need attention.</abstract><cop>Melville</cop><pub>American Institute of Physics</pub><doi>10.1063/5.0118656</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0094-243X |
| ispartof | AIP conference proceedings, 2023, Vol.2606 (1) |
| issn | 0094-243X 1551-7616 |
| language | eng |
| recordid | cdi_proquest_journals_2760676143 |
| source | AIP Journals Complete |
| subjects | Outbreaks Platforms Product safety Public health Vaccines Viral diseases |
| title | Prospect of dengue vaccine development with halal process-based technology |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T11%3A09%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_scita&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=proceeding&rft.atitle=Prospect%20of%20dengue%20vaccine%20development%20with%20halal%20process-based%20technology&rft.btitle=AIP%20conference%20proceedings&rft.au=Lestari,%20Christina%20Safira%20Whinie&rft.date=2023-01-04&rft.volume=2606&rft.issue=1&rft.issn=0094-243X&rft.eissn=1551-7616&rft.coden=APCPCS&rft_id=info:doi/10.1063/5.0118656&rft_dat=%3Cproquest_scita%3E2760676143%3C/proquest_scita%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2760676143&rft_id=info:pmid/&rfr_iscdi=true |